Chang Shin Jung

Pusan National University Yangsan Hospital

Papers

Total Citations

H-Index

About

Chang Shin Jung is a clinical researcher whose work focuses on rare and aggressive breast cancer subtypes, particularly metaplastic breast cancer (MBC). Their most-cited study, "Male metaplastic breast cancer with poor prognosis: A case report" (2022, 4 citations), addresses a critical gap in oncology literature—MBC constitutes less than 1% of breast cancers and is even rarer in males. This case report documents a male patient with MBC, highlighting its aggressive nature and resistance to standard therapies. Jung’s contribution lies in drawing attention to this understudied population, emphasizing the need for tailored treatment approaches. Despite the modest citation count, the work serves as a valuable reference for clinicians encountering similar cases. By detailing the poor prognosis and therapeutic challenges, Jung underscores the urgency of further research into MBC’s molecular drivers and novel interventions. Their research is particularly impactful for oncologists, pathologists, and medical students specializing in breast cancer, offering rare insights into a disease that remains poorly understood. Through this focused case study, Jung advances the conversation on precision medicine for rare, high-risk malignancies.